Department of Health and Human Services Secretary Michael Leavitt and
the Food and Drug Administration (FDA) broke their promise to decide by September
1 on whether to approve over-the-counter sales of the emergency contraceptive
called Plan B by its manufacturer, Barr Laboratories Inc, charged Senators
Hillary Rodham Clinton (D, NY) and Patty Murray (D, Wash).
“It is a breach of faith to have this administration give us their
word that a decision would be made, and have that promise violated. FDA’s
only criteria for approval should be safety and efficacy, not politics and
ideology,” Clinton and Murray said in a statement. They had dropped
their hold on the nomination of Lester Crawford, PhD, DVM, to head the FDA
based on Leavitt’s promise of a decision by September 1.
Mitka M. Plan B Deferred. JAMA. 2005;294(14):1752. doi:10.1001/jama.294.14.1752-b